C

CSL

Develops and delivers biotherapies and vaccines

Director – Search & Evaluation Early Therapeutic Area Lead - Haematology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • Significant tenure in biopharma, with significant experience in external innovation, search and evaluation, or business development.
  • An advanced degree (PhD, MD, or equivalent) is required.
  • Deep scientific expertise in Haematology.
  • A proven track record of leading due diligence and closing early-stage deals.
  • A strong network within biotech, academia, and pharmaceutical business development organizations.

Responsibilities

  • Serve as the senior Early Search and Evaluation leader within the Therapeutic Area Leadership Team, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
  • Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with therapeutic-area strategy.
  • Co-lead internal meetings with the Late Search Lead to evaluate and prioritize New Product Opportunities within Haematology; these meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.
  • Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.
  • Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.
  • Partner closely with Business Development and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.
  • Represent the therapeutic area externally by leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.

About the Company

CSL

Develops and delivers biotherapies and vaccines

CSL is a global biotechnology company that develops and delivers biotherapies and influenza vaccines. It focuses on plasma-derived and recombinant therapies for rare and serious diseases and sells to healthcare providers, hospitals, and governments across the Americas, Asia Pacific, and Europe. Its product range includes treatments for rare diseases, influenza vaccines, and antivenoms, produced through its R&D, manufacturing, and distribution operations. CSL differentiates itself by offering the broadest portfolio of plasma-derived and recombinant therapies and by leveraging its global footprint and emphasis on diversity to reach diverse markets. The company’s main goal is to save lives and protect health by expanding access to high-quality therapies and vaccines worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Parkville, Australia
Founded
1916

Recently Posted Jobs

Explore more opportunities at CSL

See more jobs